Evaluation of the API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism

NCT05173116 | Withdrawn

• 1 other identifier: 2020-08
• Study Type: observational
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The study was designed to evaluate the APIVIGIE program use at CH d'Arras. The objective of this program is to reduce repeated visits by the same patient to the emergency room for Alcoholism Severe Paroxysmal

Conditions

Intoxication;Alcohol;Acute; Emergencies

Keywords

Intoxication;Alcohol;Acute; Addiction, Alcohol; binge drinking; young adult

Outcome Measures

Primary Outcomes (1)

• Number of visits to the Emergency Reception Service for Significant Paroxysmal Alcoholics

  1 year before implementation of the program and up to 1 year after implementation of the program

  during 2 years

Secondary Outcomes (3)

• weekly consumption of alcoholic beverages

  Inclusion , Visit 2 (Month 3) and visit 3 (Month 6)

• weekly consumption of other substances (cannabis, other substances)

  Inclusion , Visit 2 (Month 3) and visit 3 (Month 6)

• Quality of life score, measured by the Medical Outcomes Study Short Form 36 (SF-36) health scale score.

  Inclusion , Visit 2 (Month 3) and visit 3 (Month 6)

Study Arms (2)

prospective study

API-VIGIE program adult participant who agreed to participate in the study

Other: Medical Outcomes Study Short Form 36 (SF 36)

retrospective study

Any stay for adults patients in the emergency room of the ARRAS hospital for API during the period covered (from 1 year before to 1 year after the installation of the APIVIGIE program) (main diagnosis or associated with an API (F10.0 according to the ICD-10 classification used by Department of Medical Information)

Other: observationnal study

Interventions

Medical Outcomes Study Short Form 36 (SF 36) OTHER

completion of questionnaire quality of life SF 36 (inclusion, Month 3, Month 6).

prospective study

observationnal study OTHER

data collection

retrospective study

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participant at API-VIGIE program

You may qualify if:

• Patient 18 years or older;
• Participant at API-VIGIE program.

You may not qualify if:

• Patient's opposition to participating in the research;
• Persons under legal protection (under tutorship or curatorship);
• Person deprived of liberty;
• Pregnant or breastfeeding women.

Sponsors & Collaborators

• Centre Hospitalier Arras: lead
• F2RSM Psy (Hauts-de-France Regional Federation for Research in Psychiatry and Mental Health): collaborator

Study Sites (1)

Dominique LEJEUNE

Arras, France

Location

MeSH Terms

Conditions

Alcoholic Intoxication; Emergencies; Alcoholism; Binge Drinking

Condition Hierarchy (Ancestors)

Alcohol-Related Disorders; Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Alcohol Drinking; Drinking Behavior; Behavior

Study Officials

• Dominique LEJEUNE, M.D

  Centre Hospitalier Arras

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 29, 2021
• First Posted: December 29, 2021
• Study Start: February 1, 2022
• Primary Completion: February 1, 2023
• Study Completion: August 1, 2023
• Last Updated: January 11, 2023

Record last verified: 2023-01

Locations

FR (1)